| Literature DB >> 28536641 |
Bashir Mohammed Abubakar1,2, Faezah Mohd Salleh1, Mohd Shahir Shamsir Omar3, Alina Wagiran1.
Abstract
In the last two decades, there has been a tremendous increase in the global use of herbal medicinal products (HMPs) due to their claimed health benefits. This has led to increase in their demand and consequently, also, resulted in massive adulteration. This is due to the fact that most of the traditional methods cannot identify closely related species in a process product form. Therefore the urgent need for simple and rapid identification methods resulted in the discovery of a novel technique. DNA barcoding is a process that uses short DNA sequence from the standard genome for species identification. This technique is reliable and is not affected by external factors such as climates, age, or plant part. The difficulties in isolation of DNA of high quality in addition to other factors are among the challenges encountered using the DNA barcoding in the authentication of HMP. These limitations indicated that using DNA barcoding alone may ineffectively authenticate the HMP. Therefore, the combination of DNA barcoding with chromatographic fingerprint, a popular and generally accepted technique for the assessment and quality control of HMP, will offer an efficient solution to effectively evaluate the authenticity and quality consistency of HMP. Detailed and quality information about the main composition of the HMPs will help to ascertain their efficacy and safety as these are very important for quality control.Entities:
Year: 2017 PMID: 28536641 PMCID: PMC5425840 DOI: 10.1155/2017/1352948
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Examples of polyherbal HMPs.
| Polyherbal product | Medicinal value | Composition | References |
|---|---|---|---|
| Xue-Fu-Zhu-Yu decoction | Treatment of atherosclerosis and coronary heart disease, lowering the level of cholesterol in serum |
| Zhang and Cheng [ |
|
| |||
| Ayurved Siriraj Prasachandaeng | Antipyretic drug |
| Akarasereenont et al. [ |
|
| |||
| Ge-Gen Decoction | Treatment of common cold, fever, and influenza. | Pueraria Radix (Gegen), Ephedrae Herba (Mahuang), | Yan et al. [ |
|
| |||
| Danggui-Shaoyao-San (DSS) | Treatment of gynaecological disorder such as amenorrhea and dysmenorrhea | Radix | Chen et al. [ |
|
| |||
| Shrishadi | To treat infectious respiratory disorders |
| Kajaria et al. [ |
|
| |||
| Hongdoushan capsule | Treatment of ovarian and breast cancers |
| Zhu et al. [ |
Example of some detectors used for the detection of HMPs.
| Types of HMPs | Medicinal value | Column | Detector | Chromatographic condition | References |
|---|---|---|---|---|---|
| Valerian | Neuralgia, epilepsy, and relieving digestive | VP-ODS C18 column (4.6 × 250 mm, 5 | HPLC-UV |
aAcetonitrile; 0.8 mL/min isocratically; d10 | Ghafari et al. [ |
|
| |||||
| Vidanga | Anthelmintic, carminative, and stimulant | Chromatopak Peerless basic C18 column | HPLC-PDA |
aMeOH-phosphate; b1.4 mL/min isocratically; c25°C, d20 | Sudani et al. [ |
|
| |||||
| Radix Isatidis | Influenza, epidemic hepatitis, and epidemic encephalitis B | ODS-3 Inertsil column (25 cm × 4.6 mm i.d., 5 | HPLC-DAD |
aWater-acetonitrile; b1 mL/min gradient; c35°C; d10 | Zou et al. [ |
|
| |||||
| Buyang Huanwu decoction | Promoting blood flow, treatment of cerebrovascular diseases | Zorbax SB-C18 column | HPLC-DAD-TOF/MS |
a0.3% formic acid water- acetonitrile; b0.8 mL/min gradient; c25°C; d1 | Liu et al. [ |
|
| |||||
|
| Antidiabetic, anti-inflammatory, and antitumour activities | C18 column (250 mm × 4.6 mm i.d., 5 | HPLC-ELSD |
aAcetonitrile-water-acetic acid (10 : 85 : 5, v/v/v) and Acetonitrile-water (80 : 20, v/v); b1.5 mL/min gradient; c40°C; d10 | Sun et al. [ |
|
| |||||
| Ge-Gen decoction | Treatment of common cold, fever, and influenza | Agela Venusil MP-C18 column | HPLC-Q-TOF-MS/MS |
a0.1% formic acid-water-acetonitrile; b1.0 mL/min gradient; c30°C; d10 | Yan et al. [ |
|
| |||||
|
| Anti-inflammatory, increasing coronary blood flow | Waters Symmetry C18 column (250 mm × 4.6 mm i.d., 5 | HPLC-PDA |
aAcetonitrile-phosphoric acid; b0.8 mL/min gradient; c25°C; d20 | Xu et al. [ |
|
| |||||
|
| Antipyretic and anti-inflammatory activities | C-18 column | HPLC–PDA–ELSD |
aAcetonitrile-water; b1.6 mL/min gradient; c43°C; d20 | Li et al. [ |
|
| |||||
| Renshen | Treatment of cardiovascular diseases, cancer | A CSH C18 column | HPLC/QTOF-MSE | CH3CN-H2O; b0.3 mL/min gradient; c25°C; d2 | Qiu et al. [ |
|
| |||||
|
| Anti-inflammatory, antiviral, antiallergy, and antiulcer properties | C18-HL (150 × 100 mm, 10 | HPLC-PDA | 0.1% TFA in water-0.1% of TFA in MeOH; 3.00 mL/min gradient; c25–28°C; d100 | Basar et al. [ |
|
| |||||
| Sanqi | Hemostatic and cardiovascular properties | Waters Symmetry C18 column | HPLC-UV |
aWater-acetonitrile; b1.0 mL/min gradient; c35°C; d5 | Lau et al. [ |
|
| |||||
| Renshen | Treatment of cardiovascular diseases, cancer | Waters | HPLC-APCI/MS | aAcetonitrile-water (33 : 67, v/v); b0.2 mL/min isocratically; c35°C | Ma et al. [ |
|
| |||||
|
| Anti-inflammatory and antibacterial effects | Zorbax SB-C18 column | HPLC-DAD |
aAcetonitrile-water; b1.0 mL/min gradient; c25°C; d10 | Zhao et al. [ |
|
| |||||
|
| Treatment of cough | Kromasil C18 column (200 × 4.6 mm i.d.) | HPLC-ELSD |
aAcetonitrile-water-diethylamine (70 : 30 : 0.1, v/v); 1 mL/min isocratically; c88°C, d20 | Li et al. [ |
|
| |||||
| Hongdoushan capsule | Treatment of ovarian and breast cancers | Shimadzu C18 column (4.6 × 250 mm, 5 | HPLC-PDA |
aAcetonitrile-water; b0.8 mL/min gradient; c25°C; d5 | Zhu et al. [ |
|
| |||||
|
| Improving cardiovascular activity, insomnia | Waters Spherisorb S3 ODS2 column | HPLC-APCI-MS | aAcetonitrile : water (24 : 76, v/v); b0.2 mL/min isocratically; c35°C | Ma et al. [ |
|
| |||||
|
| Suppressing fever, dispelling dampness, and antimicrobial properties | Kromasil C18 analytical column | HPLC-ELSD |
aAcetonitrile : water (30 : 70, v/v) pH was adjusted to 6.0 with 0.2 moL/L trichloroacetic acid; b2.8 L/min; c115°C; d20 | Kong et al. [ |
|
| |||||
| Menoprogen | Treatment of menopause | Kromasil ODS C18 column (4.6 × 250 mm, 5 | HPLC-PDA | 0.1% phosphoric acid- 0.1% acetonitrile; b1.0 L/min; c25°C; d10 | Wang et al. [ |
|
| |||||
|
| Dispersing painful abdominal mass | Sepax C18 column (5 | HPLC-DAD |
aAcetonitrile-methanol-polyphosphoric; b0.8 mL/min gradient; c30°C; d20 | Xu et al. [ |
|
| |||||
| Tong-Xie-Yao-Fang | Diarrhoea-predominant irritable bowel syndrome | Kromasil C18 column | HPLC-DAD-ESI-M |
aAcetonitrile-0.1% formic acid and water; b0.6 mL/min gradient; c35°C; d5 | Yan et al. [ |
|
| |||||
| Tulsi | Carcinogens, chemotherapeutic agents | C18 column | HPLC-PDA | aWater-acetonitrile; b1.0 mL/min gradient; c40°C; | Chanda et al. [ |
|
| |||||
|
| Improving cardiovascular activity, insomnia | Diamonsil C18 column | HPLC-UV–vis |
aAcetonitrile-0.5% of phosphate acid; b1.0 mL/min gradient; c35°C; d20 | Zhang et al. [ |
|
| |||||
|
| Erectile dysfunction, libido, and male infertility | C18 column | LC-MS/MS |
a0.1% formic acid in water-0.1% formic acid in acetonitrile/water (90 : 10, v/v); b0.25 mL/min gradient; c40°C; d2 | Han et al. [ |
|
| |||||
| Antike capsule | Antineoplastic property | Zorbax SB-C18 column (4.6 × 250 mm 5 | HPLC-PDA | MeCN and 0.1% HOAc–0.5% KH2PO4 aqueous solution (adjusted to pH = 2.4 with H3PO4); b0.8 mL/min gradient; c30°C; d20 | Duan et al. [ |
|
| |||||
|
| Treatment of cancer, amebic dysentery, and malaria | Agilent Eclipse | HPLC-QTOF/MS | Water-acetonitrile; b1 mL/min gradient; c25°C | Tan et al. [ |
|
| |||||
| Fufang Zhenzhu Tiaozhi | Dyslipidemia | Dionex Acclaim C18 column (250 mm × 4.6 mm, 5 | HPLC-DAD |
aAcetonitrile-potassium dihydrogen phosphate solution (40 : 60 v/v) PH adjusted to 3 with 1.7 g/L sodium dodecyl sulfate and phosphoric acid; b1.0 min/mL isocratically; c30°C; d20 | Chen et al. [ |
|
| |||||
| Black cohosh | Antipyretic and anti-inflammatory activities | C-18 column | HPLC-ELSD |
aWater-acetonitrile-alcohol; b1.0 mL/min gradient; c40°C; d10 | Ganzera et al. [ |
|
| |||||
|
| Osteoporosis, osteomalacia | Zorbax SB-C18 column | HPLC-DAD-TOFMS-QITMS |
a0.1% aqueous formic acid-acetonitrile; b0.6 mL/min; gradient; c30°C; d10 | Tan et al. [ |
|
| |||||
|
| Antimicrobial, tranquilizer, and hypotensive treatments | Hypersil, UK, ODS2 column (200 × 4.0 mm i.d., 5 | HPLC-ELSD |
aMethanol-water; b0.8 mL/min gradient; c30°C; d10 | Kong et al. [ |
|
| |||||
| Xue-Fu-Zhu-Yu decoction | Atherosclerosis and coronary heart disease | Zorbax | HPLC-ESI-MS | a(CH3COOH:H2O)-(CH3OH); b0.5 mL/min gradient; c30°C | Zhang and Cheng [ |
|
| |||||
|
| Treatment of pain, inflammation, and immune and hepatic disorders | Altima C18 ODS column (4.6 × 250 mm, 5 | HPLC-DAD |
aAcetonitrile with 0.02% TFA-water with 0.5% TFA; b1.0 mL/min gradient; c30°C; d10 | Bian et al. [ |
|
| |||||
| Danggui-Shaoyao-San | Dysmenorrhea, amenorrhea | Alltima C18 column (250 mm × 4.6 mm i.d., 5 | HPLC-DAD-ESI-MS | aAcetonitrile-water-formic acid; b1 mL/min gradient; c30°C | Chen et al. [ |
|
| |||||
| Ojeok-san | Primary dysmenorrheal, clastogenicity | Gemini C18 column | HPLC-DAD |
a0.1% formic acid in water-acetonitrile; b1.0 mL/min gradient; c40°C; d10 | Kim et al. [ |
|
| |||||
| Gui-Zhi-Jia-Shao-Yao-Tang | Effect against peptic ulcer by alleviating gastrospasm | Zorbax SB-C18 Rapid Resolution HT column (4.6 mm × 50 mm, 1.8 | LC-MS and NMR |
a0.05% formic acid in water-acetonitrile; b0.6 mL/min gradient; c30°C; d3 | Wang et al. [ |
|
| |||||
| Renshen | Cardiovascular diseases, cancer | Capcell Pak C18 column (250 mm × 4.6 mm i.d., 5 | HPLC-ESI-MS |
a0.2% acetic acid in water-acetonitrile; b0.5 mL/min gradient; c35°C; d10 | Zhang et al. [ |
|
| |||||
| Sanqi | Hemostatic and cardiovascular properties | Agilent Eclipse XDB-C18 column | HPLC-QTOF/M | a0.1% aqueous formic acid-acetonitrile containing a0.1% formic acid; b0.8 mL/min gradient; c25°C; | Tan et al. [ |
aMobile phase; bflow rate; ctemperature; dinjection volume.
HPLC-UV: Ultraviolet-Visible detector; HPLC-DAD: liquid chromatography-diode-array detector; HPLC-PDA: liquid chromatography photodiode-array; HPLC-ELSD: liquid chromatography evaporative light scattering detector; LC-MS: liquid chromatography-mass spectrometric detector; NMR: nuclear magnetic resonance; HPLC-DAD-ESI-MS: liquid chromatography-diode-array detector-electrospray ionization-mass spectrometry; HPLC-APCI-MS: liquid chromatography–atmospheric-pressure chemical ionization-mass spectrometry; HPLC- DAD-TOF/MS: liquid chromatography-diode-array detector-time of flight-mass spectrometry; LC-MS and NMR: liquid chromatography-mass spectrometry-nuclear magnetic resonance; HPLC-QTOF/MS: liquid chromatography-quadrupole time of flight-mass spectrometry; HPLC-ESI-MS: liquid chromatography-electrospray ionization-mass spectrometry; HPLC-DAD-TOFMS-QITMS: liquid chromatography-diode-array detector-time of flight-mass spectrometry-quadrupole ion trap mass spectrometry; LC-MS/MS: liquid chromatography-mass spectrometry/mass spectrometry; HPLC-PDA-ELSD: Liquid chromatography-photodiode-array-evaporative light scattering detector.
Examples of some selected qualitative, quantitative, and semiquantitative analysis of HMPs.
| Types of HMPs | Medicinal value | Type of analysis | Method of analysis | Reference |
|---|---|---|---|---|
|
| Treatment of cancer, amebic dysentery, and malaria | Qualitative analysis | HPLC-QTOF/MS | Tan et al. [ |
|
| ||||
|
| Treatment of fevers, ulcers, cancers, and inflammation | Qualitative analysis | HPLC-DAD-MS | Horvath et al. [ |
|
| ||||
|
| Treatment of blood disorders, ischemia, and swelling | Qualitative analysis | HPLC-DAD/ESI-MS/MS | Liu et al. [ |
|
| ||||
| Sanqi | Hemostatic and cardiovascular properties | Qualitative analysis | HPLC-QTOF/MS | Tan et al. [ |
|
| ||||
| Radix Angelicae Dahuricae | Anticancer and antibacterial properties | Quantitative analysis | HPLC-ESI-MS/MS | Zheng et al. [ |
|
| ||||
|
| High antioxidant and antiproliferative activities | Quantitative analysis | LC-ESI-MS | Skhirtladze et al. [ |
|
| ||||
| Shenqi Fuzheng injection (SFI) | Good immunoenhancement and anticancer activity | Quantitative analysis | SPE-HPLC-UV/ELSD | Wang and Qu [ |
|
| ||||
| Sanqi | Hemostatic and cardiovascular properties | Quantitative analysis | HPLC-QTOF/MS | Tan et al. [ |
|
| ||||
| Rhubarb | Cathartic and laxative properties | Semiquantitative analysis | HPLC-DAD | Gao et al. [ |
|
| ||||
|
| Treatment of chronic cough, lungs cancer | Semiquantitative analysis | LC/ESI-TOF-MS | Zhou et al. [ |
|
| ||||
|
| Treatment of cancer, amebic dysentery, and malaria | Semiquantitative analysis | HPLC-ELSD | Tan et al. [ |
|
| ||||
|
| Antioxidant, anti-inflammatory, antimicrobial, and anticancer | Semiquantitative analysis | LC/ESI-MS | Cavaliere et al. [ |
HPLC-DAD: liquid chromatography-diode-array detector; HPLC-DAD-MS: liquid chromatography-diode-array detector-mass spectrometry; HPLC-DAD/ESI-MS/MS: liquid chromatography-diode-array detector/electrospray ionization-mass spectrometry/mass spectrometry; HPLC–ESI-MS/MS: liquid chromatography-electrospray ionization-mass spectrometry/mass spectrometry; HPLC-DAD-TOF/MS: liquid chromatography-diode-array detector-time-of-flight-mass spectrometry; HPLC-DAD-ESI-MS: liquid chromatography-diode-array detector-electrospray ionization-mass spectrometry; HPLC-QTOF/MS: liquid chromatography-quadrupole time-of-flight- mass spectrometry; LC-MS/MS: liquid chromatography-mass spectrometry-mass spectrometry; LC/ESI-TOF-MS: liquid chromatography/electrospray ionization time of flight mass spectrometry; SPE-HPLC-UV/ELSD: solid-phase extraction, high performance liquid chromatography, and ultraviolet/evaporative light scattering detection.
Example of some chemometric methods used for the analysis of HMPs.
| Types of HMPs | Medicinal value | Methods of analysis | Chemometrics method | Reference |
|---|---|---|---|---|
| Basil ( | Antimicrobial and antioxidant properties | HPLC-DAD | PCA | Grayer et al. [ |
|
| ||||
| Radix Isatidis | Influenza, epidemic hepatitis, and epidemic encephalitis B | RP-HPLC | HCA | Zou et al. [ |
|
| ||||
|
| Diminishing inflammation, relieving a cough, and stimulating the appetite | HPLC–PAD | PCA, HCA | Peng et al. [ |
|
| ||||
| Flos Lonicerae Japonicae | Treatment of bacterial and virus diseases, inflammation, and fever | HPLC-DAD | HCA | Li et al. [ |
|
| ||||
|
| Anti-inflammatory, antibacterial, and antidepressant agent | HPLC-DAD-ELSD | PCA | Hong-Lan et al. [ |
|
| ||||
|
| Improving eyesight and medicinal values as a cathartic and diuretic | HPLC-DAD | PCA, PLS, BP-ANN, and RBF-ANN | Lai et al. [ |
|
| ||||
|
| Strong fungicidal activity, antioxidant activity | HPLC-DAD | PCA | Vieira et al. [ |
|
| ||||
|
| Immunity stimulant and antitumour activities | HPLC-DAD | PCA, HCA | Guo et al. [ |
|
| ||||
|
| Eliminating sputum and dispersing painful abdominal mass | HPLC-DAD | PCA, HCA, SA | Xu et al. [ |
PCA: principal component analysis; HCA: hierarchical clustering analysis; PLS: partial least squares; BP-ANN: back propagation artificial neural network; RBF-ANN: radial basis function artificial neural network; HPLC-DAD: liquid chromatography-diode-array detector; HPLC-PDA: liquid chromatography photodiode-array; HPLC-DAD-ELSD: liquid chromatography-diode-array detector-evaporative light scattering detection; HPLC-APCI-MS: liquid chromatography–atmospheric-pressure chemical ionization-mass spectrometry; RP-HPLC: reverse-phase liquid chromatography; LDA: linear discriminant analysis; SA: similarity analysis; PLS: partial least square.
Different DNA extraction methods that have been used in HMPs.
| Method used | Extraction method | Reference/supplier | Medicinal parts/type of HMPs | References |
|---|---|---|---|---|
| Roots, leaves, powder, stem, seeds, whole plant | Vassou et al. [ | |||
| Leaves and fruit | Srirama et al. [ | |||
| Juice | Mahadani and Ghosh [ | |||
| Leaves | da Costa et al. [ | |||
| Fruits, stem, seeds, herb, cortex, flowers, rhizome | Han et al. [ | |||
| Modified CTAB methods | Salting out precipitation | Doyle [ | Herb | Kumar et al. [ |
| Leaves | Alexander [ | |||
| Herb | Li et al. [ | |||
| Leaves | Costa et al. [ | |||
| Dry leaves, bark, fruit | Seethapathy et al. [ | |||
| Leaves | Selvaraj et al. [ | |||
| Powder | Sheth and Thaker [ | |||
| Herbs | Cheng et al. [ | |||
| Roots | Zhou et al. [ | |||
| Rhizome | Wong et al. [ | |||
|
| ||||
| Modified SDS methods | Salting out precipitation | Leaves, flower, bud | Tamari et al. [ | |
| Edwards et al. [ | Leaves | Alexander [ | ||
| Leaves | da Costa et al. [ | |||
| Herbs | Cheng et al. (2014) | |||
|
| ||||
| Wizard Genomic DNA purification kit | Silica binding | Promega | Tea | Jian et al. [ |
|
| ||||
| Capsule, tablets, powder, leaf | Newmaster et al. [ | |||
| Dried and fresh plant tissue, capsule, tea, dried bark | Singtonat and Osathanunkul [ | |||
| NucleoSpin plant II mini | Silica binding | Macherey-Nagel | Tea | Uncu et al. [ |
| Plant tissue | Osathanunkul et al. [ | |||
| Seeds | Costa et al. [ | |||
| Dried plant tissue | Osathanunkul et al. [ | |||
| Leaves, pills, cone, stem, roots, bark | Llongueras et al. [ | |||
|
| ||||
| NuceloSpin Tissue Kits | Silica binding | Macherey-Nagel | Tea, roots, capsule, liquid, root pieces, tablets | Wallace et al. [ |
|
| ||||
| Bark | Palhares et al. [ | |||
| Capsule, tablets | Baker [ | |||
| Leaves | da Costa et al. [ | |||
| Leaves, flower, roots | Palhares et al. [ | |||
| DNeasy Plant mini kit | Silica binding | Qiagen | Leaves, pills, cone, stem, roots, bark | Llongueras et al. [ |
| Powder | Cimino [ | |||
| Leaves | Alexander [ | |||
| Leaves | Enan and Ahmed [ | |||
| Fruit, powder | Parvathy et al. [ | |||
|
| ||||
| DNeasy96 Plant kit | Silica binding | Qiagen | Tea | Stoeckle et al. [ |
|
| ||||
| Plant Genomic DNA Kit | Silica binding | Tiangen Biotech | Decoction | Xin et al. [ |
| Dried bulbus | Xiang et al. [ | |||
| Leaves, cortex | Zhang et al. [ | |||
| Crude drug, dry leaf, root | Zhu et al. [ | |||
| Root, pills, capsule, tablets | Liu et al. [ | |||
| Dry fruit, leaves | Dian-Yun et al. [ | |||
| Dry leaves, roots | Hu et al. [ | |||
| Dry flower bud | Hou et al. [ | |||
|
| ||||
| IBI genomic DNA mini kit (plant, GP1) | Silica binding | IBI | Leaves, pills, cone, stem, roots, bark | Llongueras et al. [ |
Overview of chemical and DNA barcoding methods for herbal medicinal plant identification.
| Analysed material | Chemical methods applied | Genomic region analysed | References |
|---|---|---|---|
|
| HPLC |
| Palhares et al. [ |
|
| |||
|
| HPLC and TLC |
| Li et al. [ |
|
| |||
|
| HPLC and TLC | ITS2 | Li et al. [ |
|
| |||
|
| HPLC and TLC |
| Palhares et al. [ |
|
| |||
|
| HPLC | ITS2 | Jian-ping et al. [ |